Tempus AI Inc. TEM, a cutting-edge healthcare diagnostics company, has been on a tear. The stock established a new high of $47.81 on Thursday.
The stock is up 17.27% since its IPO in June. The company, which went public at $37 per share, and has been riding a wave of momentum ever since.
Over the past five days, Tempus is up about 25% — a spike largely attributed to a strategic investment from SoftBank Group Corp SFTBF SFTBY.
According to SoftBank’s second-quarter 13F filing, the investment giant added Tempus AI to its portfolio, acquiring approximately 5.41 million shares (worth approx. $189 million).
Google also backs Tempus AI.
This move, alongside SoftBank’s increased stake in AI heavyweight Nvidia Corp NVDA, underscores the firm’s bullish stance on the AI sector.
Read Also: Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%
Positive Signals: Tempus Rising
From a technical perspective, Tempus AI’s stock is showing strong bullish signals.
Chart created using Benzinga Pro
With its share price comfortably above key moving averages—such as the eight-day SMA at $42.02 and the 20-day SMA at $41.51—the stock is poised for sustained upward momentum.
The absence of data for the 50-day and 200-day SMAs, owing to the stock’s recent market entry, does not diminish the prevailing positive sentiment.
Investors are evidently recognizing the potential of Tempus AI, particularly with the support of industry giants like Google and SoftBank.
As the company continues to innovate and broaden its AI-driven healthcare solutions, its stock could remain a sought-after asset on the Nasdaq, enticing those seeking to ride the wave of the AI revolution.
The crucial question now lingers: can Tempus AI uphold this momentum and persist in forging new paths in the swiftly evolving tech terrain?
Read Next:
